Relapse-associated microRNA in gastric cancer patients after S-1 adjuvant chemotherapy

Author：

ISSN： 1021-335X

Source： Oncology Reports, Vol.31, Iss.2, 2014-01, pp. : 613-618

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Survival and prognosticators of gastric cancer that recurs after adjuvant chemotherapy with S-1

By Aoyama Toru

Gastric Cancer, Vol. 14, Iss. 2, 2011-06 ,pp. : 150-154

Springer Publishing Company

Access to resources Recommend Favorite

Tolerability of adjuvant chemotherapy with S-1 after curative resection in patients with stage II/III gastric cancer

Oncology Letters, Vol. 4, Iss. 5, 2012-01 ,pp. : 1135-1139

Spandidos Publications

Access to resources Recommend Favorite

Evaluation of the optimal dosage of S-1 in adjuvant SOX chemotherapy for gastric cancer

Oncology Letters, Vol. 9, Iss. 3, 2015-01 ,pp. : 1451-1457

Spandidos Publications

Access to resources Recommend Favorite

Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy

By Huang Zhao-Hui Hua Dong Du Xiang

Cancer Chemotherapy and Pharmacology, Vol. 64, Iss. 5, 2009-10 ,pp. : 1001-1007

Springer Publishing Company

Access to resources Recommend Favorite

Feasibility study of S-1 adjuvant chemotherapy in patients with colorectal cancer

By Ogawa Masaichi Watanabe Michiaki Kobayashi Tetsuya Eto Ken Oda Akihiro Anan Tadashi Hayashi Takenori Mitsuyama Yoshinobu Yanaga Katsuhiko

International Journal of Clinical Oncology, Vol. 18, Iss. 4, 2013-08 ,pp. : 678-683

Springer Publishing Company

Access to resources Recommend Favorite